Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2141569
Abstract: ABSTRACT Background Efficacy and safety of ultra-rapid acting oral prandial insulin Tregopil was compared with insulin aspart (IAsp) in patients with type 2 diabetes (T2D) on insulin glargine and metformin. Research design and methods In… read more here.
Keywords: rapid acting; safety; iasp; tregopil ... See more keywords
Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum.
Sign Up to like & getrecommendations! Published in 2017 at "Bioanalysis"
DOI: 10.4155/bio-2017-0020
Abstract: AIM Tregopil, a novel PEGylated human insulin is in clinical development for oral delivery in diabetes treatment. The aim of the study was to develop and validate a sensitive and specific ELISA method for quantitating… read more here.
Keywords: insulin; tregopil; electrochemiluminescent elisa; diabetes mellitus ... See more keywords